Bill Commons

NJ S 4194

enacted

Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

New Jersey · 222 · upper

Quick answers

Did NJ S 4194 pass?

Yes. NJ S 4194 has been enacted into law as of 2026-06-30. Latest recorded action (2026-06-30): Substituted by A4852 (ACS)

What is NJ S 4194 about?

NJ S 4194 is a bill in the 222 titled “Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*”.

Who sponsors NJ S 4194?

Vitale, Joseph F., Gopal, Vin, Mukherji, Raj are the primary sponsors of NJ S 4194.

Introduced
2026-05-11
Latest action
2026-06-30 — Substituted by A4852 (ACS)
Bill type
bill
Last updated

Sponsors

  • Vitale, Joseph F.primary
  • Gopal, Vinprimary
  • Mukherji, Rajprimary

Committees

Not provided by source.

Action timeline

  1. 2026-05-11

    Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

    introduction,referral-committee

  2. 2026-06-11

    Reported from Senate Committee as a Substitute, 2nd Reading

    reading-2

  3. 2026-06-30

    Substituted by A4852 (ACS)

Versions

Documents

Votes

Not provided by source.

Related bills

  • substituted-by: A 4852
  • Companion bill: A 4852 (ACS)not in this corpus

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:27:43.923511Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NJ&identifier=S 4194. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.